chr10-16824539-G-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_001081.4(CUBN):​c.*436C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00142 in 155,842 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0015 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00024 ( 0 hom. )

Consequence

CUBN
NM_001081.4 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.519

Publications

0 publications found
Variant links:
Genes affected
CUBN (HGNC:2548): (cubilin) Cubilin (CUBN) acts as a receptor for intrinsic factor-vitamin B12 complexes. The role of receptor is supported by the presence of 27 CUB domains. Cubulin is located within the epithelium of intestine and kidney. Mutations in CUBN may play a role in autosomal recessive megaloblastic anemia. [provided by RefSeq, Jul 2008]
CUBN Gene-Disease associations (from GenCC):
  • Imerslund-Grasbeck syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
  • proteinuria, chronic benign
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Imerslund-Grasbeck syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00149 (220/147336) while in subpopulation AFR AF = 0.00523 (209/39958). AF 95% confidence interval is 0.00465. There are 1 homozygotes in GnomAd4. There are 109 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CUBNNM_001081.4 linkc.*436C>A 3_prime_UTR_variant Exon 67 of 67 ENST00000377833.10 NP_001072.2 O60494
CUBNXM_011519709.3 linkc.*436C>A 3_prime_UTR_variant Exon 41 of 41 XP_011518011.1
CUBNXM_011519710.3 linkc.*436C>A 3_prime_UTR_variant Exon 41 of 41 XP_011518012.1
CUBNXM_011519711.4 linkc.*436C>A 3_prime_UTR_variant Exon 40 of 40 XP_011518013.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CUBNENST00000377833.10 linkc.*436C>A 3_prime_UTR_variant Exon 67 of 67 1 NM_001081.4 ENSP00000367064.4 O60494

Frequencies

GnomAD3 genomes
AF:
0.00146
AC:
215
AN:
147220
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00512
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000682
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000498
GnomAD4 exome
AF:
0.000235
AC:
2
AN:
8506
Hom.:
0
Cov.:
0
AF XY:
0.000224
AC XY:
1
AN XY:
4470
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
160
American (AMR)
AF:
0.00
AC:
0
AN:
1386
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
92
East Asian (EAS)
AF:
0.00
AC:
0
AN:
606
South Asian (SAS)
AF:
0.00
AC:
0
AN:
1082
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
170
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
16
European-Non Finnish (NFE)
AF:
0.000436
AC:
2
AN:
4582
Other (OTH)
AF:
0.00
AC:
0
AN:
412
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.250
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.00149
AC:
220
AN:
147336
Hom.:
1
Cov.:
32
AF XY:
0.00152
AC XY:
109
AN XY:
71626
show subpopulations
African (AFR)
AF:
0.00523
AC:
209
AN:
39958
American (AMR)
AF:
0.000681
AC:
10
AN:
14678
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3420
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5032
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4662
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9430
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
286
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66946
Other (OTH)
AF:
0.000492
AC:
1
AN:
2032
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00126
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Imerslund-Grasbeck syndrome type 1 Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.16
DANN
Benign
0.56
PhyloP100
-0.52

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs574512019; hg19: chr10-16866538; API